Coherus Biosciences reported $97.73M in Equity Capital and Reserves for its fourth fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Aerie Pharmaceuticals AERI:US $ -17.33M 55.54M
Bluebird Bio BLUE:US $ 374.28M 496.25M
Ironwood Pharmaceuticals IRWD:US $ 517.78M 88.13M
LG Chem 051910:KS KW 21693784M 368684M
Myriad Genetics MYGN:US $ 967.8M 0.8M
Teva Pharmaceutical TEVA:IT 10.28B 189M
Xencor XNCR:US $ 763.02M 29.52M
Zoetis ZTS:US $ 4543M 136M